1. 384: OUTCOMES OF ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING INDUCTION CHEMOTHERAPY TRANSFERRED TO THE ICU. Issue 12 (December 2015) Authors: Koch, Abby; Ahmed, Tamjeed; Isom, Scott; Klepin, Heidi; Bishop, Jonathan; Ellis, Leslie; Powell, Bayard; Pardee, Timothy Journal: Critical care medicine Issue: Volume 43:Issue 12(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. (14th February 2014) Authors: Coutre, Steven E.; Othus, Megan; Powell, Bayard; Willman, Cheryl L.; Stock, Wendy; Paietta, Elisabeth; Levitan, Denise; Wetzler, Meir; Attar, Eyal C.; Altman, Jessica K.; Gore, Steven D.; Maher, Tracy; Kopecky, Kenneth J.; Tallman, Martin S.; Larson, Richard A.; Appelbaum, Frederick R. Journal: British journal of haematology Issue: Volume 165:Number 4(2014:May) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. Issue 12 (December 2018) Authors: Eisfeld, Ann-Kathrin; Kohlschmidt, Jessica; Mrózek, Krzysztof; Mims, Alice; Walker, Christopher; Blachly, James; Nicolet, Deedra; Orwick, Shelley; Maharry, Sophia; Carroll, Andrew; Powell, Bayard; Kolitz, Jonathan; Wang, Eunice; Stone, Richard; Chapelle, Albert; Byrd, John; Bloomfield, Clara Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗